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Abstract
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a quantitative trait locus on
chromosome 6q23 was significantly associated with HbF and F cell levels in individuals of African descent. Single nucleotide
polymorphisms (SNPs) in a 24-kb intergenic region, 33-kb upstream of the HBS1L gene and 80-kb upstream of the MYB
gene, were typed in 177 healthy Afro-Caribbean subjects (AC) of approximately 7% European admixture, 631 healthy Afro-
Germans (AG, a group of African and German descendents located in rural Jamaica with about 20% European admixture), 87
West African and Afro-Caribbean individuals with sickle cell anaemia (HbSS), as well as 75 Northern Europeans, which served
as a contrasting population. Association with a tag SNP for the locus was detected in all four groups (AC, P= 0.005, AG,
P= 0.002, HbSS patients, P= 0.019, Europeans, P= 1.561027). The association signal varied across the interval in the African-
descended groups, while it is more uniform in Europeans. The 6q QTL for HbF traits is present in populations of African
origin and is also acting in sickle cell anaemia patients. We have started to distinguish effects originating from European and
African ancestral populations in our admixed study populations.
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Introduction
The persistence of fetal haemoglobin (HbF, a2c2) production
beyond early childhood provides a major clinical benefit in patients
with sickle cell anaemia (HbSS) and b-thalassaemia. HbF is restricted
to a sub-population of erythrocytes, called F cells[1], the abundance
of F cells, and HbF, is subject to strict genetic control[2]. Various
studies in diverse populations have established the influence of the b
globin gene cluster (HBB) on chromosome 11p15 and the Gc
promoter on HbF; the causal variant here is thought to be a single-
base substitution (T/C) at position 2158 of the Gc globin gene,
termed XmnI Gc site[3]. Two other loci influencing F-cell levels have
recently been discovered[4–6]; the HMIP locus (HBS1L-MYB
Intergenic Polymorphism) on chromosome 6q was first discovered in an
Asian-Indian family with b thalassaemia and persistence of HbF, and
subsequently mapped in European samples to the interval between
two genes, theMYB oncogene and the putative HBS1L[4]. The third
major locus is the oncogene BCL11A on chromosome 2[5,6].
In Europeans, these three genetic loci contribute nearly half of all
F-cell variability: the XmnI Gc site on chromosome 11p15 accounts
for 10% of the variance; the HMIP locus on chromosome 6q, 19%;
and BCL11A on chromosome 2p, 15%[5]. At the HMIP locus, the
genetic variants reside in three linkage disequilibrium (LD) blocks,
HMIP-1, 2 and 3. Genetic variants in the three blocks completely
account for the variance in FC levels due to the 6q QTL, but most of
the effect is concentrated in HMIP-2. This block is characterised by
eleven SNPs, which can not be resolved genetically in European
subjects, because they are in strong LD with each other and show
equal strength of association with the F-cell trait[4]. We decided to
investigate these SNPs in African-descended populations to test
whether an effect is present, and whether the haplotype make-up in
African-descended populations might facilitate further resolution
and eventual fine-mapping of the causative genetic variation
underlying HbF and FC levels in the 6q QTL.
Here, we present results showing that an effect of the HMIP-2
block on F cell levels can be detected in two healthy African-
descended populations from Jamaica, and that the same locus also
influences HbF levels in HbSS patients of African descent. Associa-
tion across the 24-kb region is far more varied in African than in
European haplotypes, which suggests that future fine-mapping studies
will be able to pinpoint functionally active sequence variation.
Methods
Ethics Statement
Ethical approval was given by the University Hospital of the
West Indies/University of the West Indies Faculty of Medical
Sciences Ethics committee (study #21) and the Ministry of Health
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of Jamaica Ethics Committee (study #150); and the local King’s
College Hospital Ethics committee (No. 01-083).
All participants provided written informed consent
Participants
Three population samples were recruited and phenotyped in
Jamaica: 177 healthy blood donors from Kingston (Afro-
Caribbean group, AC); 631 healthy subjects composed of families
and unrelated individuals (Afro-German group, AG) from Seaford
Town, Westmoreland; and 75 healthy European expatriates. The
AC group is mostly of African descent, with an approximately 7%
of European genetic ancestry[7]. The AG group is from a small
population with additional European ancestry originating from
19th century German immigrants, with about 20% European
admixture[7], but otherwise similar to the AC group. All
individuals were screened for sickle cell disease and b thalassaemia
by haemoglobin electrophoresis and those who were affected were
excluded from further analysis.
In a separate study, 87 HbSS patients (49 female, 38 male) of
Afro-Caribbean and West African descent were recruited from the
specialist clinic in the Haematology Outpatient Unit of King’s
College Hospital in South London. Our patient group is ethnically
heterogeneous; about a third is of African-Caribbean decent and the
rest of West-African origins. The extent of European admixture has
not yet been measured. At the time of the study, the patients ranged
from 11 to 64 years of age, with an average age of 30 years. Dates of
blood transfusion were noted and no patient had been transfused
during the preceding three months, or had been receiving
hydroxycarbamide at the time when the HbF values were obtained.
Phenotyping
In most healthy individuals fetal haemoglobin levels are low,
with a considerable proportion of subjects having values below
0.3% HbF; in this range current HPLC measurements are very
imprecise, and the traits better represented by F cells in normals. A
major determinant of HbF levels is the number of HbF carrying
cells, referred to as F cells which shows 89% heritability[2]. We
have previously shown that there is a strong correlation between
HbF and F cell levels in the range encountered in healthy
individuals (Tatu, T., DPhil Thesis 2001, University of Oxford;
Creary, L., PhD Thesis 2007, University of London). The
proportion of F cells among erythrocytes was estimated by flow
cytometry[8] using an anti c globin antibody. For our group of
HbSS patients, F-cell data are not available, but the HbF
proportion of total haemoglobin is routinely measured for all
patients visiting our clinic by high pressure liquid chromatography
(HPLC) on a BioRad Variant II system. HbF levels encountered in
HbSS patients are between 1% to 30%, values that can be
measured accurately and precisely by HPLC. HbF and FC values
were log transformed for the study.
Genotyping
Genotyping for XmnI Gc (rs7482144) was performed by PCR/
restriction enzyme analysis[9], and for all HMIP-2 markers, by
TaqMan (Applied Biosystems, Foster City, Ca), a hybridisation
based procedure. Some primers and fluorescent MGB probes were
purchased from Applied Biosystems as pre-designed assays (with
the assay number in brackets): for rs9376090 (C___3119885_10),
rs11759553 (C___3119886_10), rs9376092 (C__27440941_10),
rs9389269 (C__27440940_10), rs9402686 (C___2737531_10),
and rs11154792 (C___3119892_10). Other Taqman assay primers
and probes were custom designed: rs4895440 (Forward: 59–
GCTGGTTATGGGAATAGAGAGTGATG–39, Reverse: 59–
CTCACTTACTCAGTTCTCTGCTCAT–39, CTTTACAAA-
GAGTCTTTCC–VIC, TTTACAAAGAGACTTTCC–FAM),
rs9399137 (Forward:59–CATCACCTTAAAAGGCGGTATTG-
TATG–39, Reverse: 59–GATTCCACTTTCAGAACTTATCC-
CAAGA, AAAAACTGTGAATAACC–VIC, AAAAAACTG-
TAAATAACC–FAM), rs9402685 (Forward:59–TGAGATTAC-
AGGCGCATGCAA–39, Reverse:59–ACTGAGGCAGGTGGA-
TTGC–39, TTCGAGAGCAACCTGA–VIC, TCGAGAGCAG-
CCTGA–FAM), rs35959442 (Forward:59–CCCAGAGCGTCC-
AAGGG–39, Reverse:59–CAAAGAACAGGTGCCTCTAGTT-
GT–39, CTACAGCAGGCTTCAG–VIC, CTACAGCAGCCT-
TCAG–FAM), and rs4895441 (Forward:59–GCTGGTTATGG-
GAATAGAGAGTGATG–39, Reverse:59–GTTATCTCCCTC-
ACTTACTCAGTTCTC–39, CTCTTTGTAAAGTGATACA-
TG–VIC, TCTTTGTAAAGTGGTACATG–FAM). Primers
and probes were designed at the Centre National de Ge´notypage
in Evry, France[4].
Statistical methods
Genetic association of FC and HbF traits with HMIP-2 marker
alleles was tested by multiple regression (SPSS v.12) including
covariates age, sex, and additive effects of the beta globin gene
locus (i.e., the XmnI Gc polymorphism).
Linkage disequilibrium (LD) between markers and the presen-
tation of marker haplotypes was investigated with Haploview
v.3.31[10] and Phase v2.1.1[11]. The effective number of
haplotypes[12] was calculated as ne = 1/Spi
2, where pi are the
individual haplotype frequency estimates.
Results
Eleven SNPs which mark the HMIP-2 block define two
complementary haplotypes in European expatriates (Figure 1A); each
SNP’s minimum allele frequency (MAF) is approximately 30% in this
population of European descent (Table 1). By contrast, MAFs in the
African-descended populations ranged from 2–38% (Table 1) and
there was more haplotype diversity (effective number of haplotypes
ne=3.7 and 3.3 in AC and AG groups, compared to 1.9 in
Europeans), with the region subdivided into two extended blocks
(Figure 1B & 1C). SNP I-02 (rs9399137), which tags the European
HMIP-2 block[4], is relatively infrequent in African-descended
populations (MAF#9%) compared to Europeans (MAF=29%).
All 11 SNPs show strong association (P#761027) with FC levels
in the European sample (Table 1) in a pattern consistent with a
previous analysis of a European British population[4]. Multiple
SNPs showed association (P-values range from 1.161025–0.045)
with FC andHbF levels in both healthy individuals and patients with
HbSS of African descent (Table 1 and 2); unlike the European
population, association was considerably variable within and
between these populations. The variability in the strength of
association was also evident in the magnitude of the beta-coefficients
(Table 1 and 2). SNP I-02 (rs9399137) shows association with FC
levels in healthy AC and AG participants (P=0.005 and 0.002,
respectively) and with HbF levels (P=0.019) in the group of HbSS
patients. Six out of eleven markers show no significant association in
the AC population. In the AG population, a wide spectrum of
association was observed, one marker (I-03) showed no association
while markers in the distal part of the block showed strong
association with P-values in the region of 1025 (I-09 to I-11, Table 1).
In the HbSS patients, just two markers (I-02 and I-07) showed
significant association with HbF (Table 2).
To examine the importance of the very strong European-tagged
association in our admixed Caribbean study subjects, we repeated
the above association analysis after excluding individuals who
carry the C allele of the rs9376090 (I-01) marker. According to
6q and HbF in African People
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HapMap data[13], this marker is invariant (MAF=0) in Yoruba
subjects from Nigeria and is a frequent polymorphism in
populations of European (C allele frequency = fC= 22%), Chinese
(fC = 29%) and Japanese (fC = 34%) descent. Since association at
the HMIP-2 locus in European chromosomes is efficiently
captured by the I-01 dimorphism[4], elimination of carriers of
the C allele should eliminate the influence of non-African genetic
variants at this locus. Association detected with the remaining
subjects will then be derived mainly from the action of other alleles
that are common in Africans, i.e. that reflect genetic variability
within the African lineage or ancient alleles that are prevalent in
multiple continental ancestry groups.
Figure 1. Linkage disequilibrium patterns and haplotype blocks in the Afro-Caribbean, Afro-German and Caucasian populations.
Pairwise linkage disequilibrium, measured by D9, of the SNPs in the 24-kb intergenic region and common haplotype structures in the Afro-Caribbean
(A), Afro-German (B), and Caucasian (C) populations. The location of each genotyped SNP located on chromosome 6q is shown on the white bar at
the top of each diagram. The magnitudes of LD between respective pairs of SNPs are shown in each square. Squares without values represent
complete LD (D9=1). The standard colour scheme of Haploview was used to display the strength of LD. Where, for LOD.2 complete LD is shown as
bright red (D9=1), and runs through to pink (D9,1) then to white (D9= 0). LOD,2 are represented as white squares. Haplotypes with a frequency
greater than 1% are shown. Within each haplotype (H1 to H7), blue blocks represent the reference allele, whereas red blocks represent the alternative
allele. Numbers next to each haplotype block are haplotype frequencies. Bold lines joining haplotypes from each block represent combined
haplotypes with frequencies .0.1%, and thin lines are for frequencies ,0.1%. In the crossing areas between haplotype blocks, a value of multi-allelic
D9 is shown to represent the level of recombination between blocks.
doi:10.1371/journal.pone.0004218.g001
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After elimination of individuals with the C allele at the I-02marker,
association was largely reduced, but a strong association signal
persisted in the distal portion of the HMIP-2 region (in the combined
AC+AG groups: I-09, P=6.561024; I-10, P=4.4610204; and I-11,
P=0.003, Table 1). Marginally significant variation also remained in
the HbSS patients (P=0.049 at I-02, Table 2).
Discussion
We report on the association of genetic variation in a 24-kb
HBS1L-MYB intergenic fragment, termed HMIP-2, with fetal
haemoglobin traits in three admixed populations of predominant
African heritage. Association with Fcell levels was detected in two
healthy population samples from Jamaica and with HbF levels in a
small group of patients with sickle cell anaemia from the UK. The
latter result confirms a recent replication of the HMIP-2 locus in
patients with sickle cell disease from the US and Brazil[14].
Dominance effects were largely not detected (with the exception of
I-11 in the AG group), which is likely due to a lack of statistical
power and of homozygotes for the minor allele in African-
descended populations.
A strong effect of this genomic region was originally seen in
Europeans[4,6]. The replication of these results in individuals of
African descent is significant for two reasons. First, a large
proportion of people with sickle cell disease, a disease which
benefits from raised HbF, have predominantly African ancestry.
Second, the study of multiple populations, especially those from
Africa, offers insights into genetic mechanisms and might help
reduce the size of the region of causative variation. Investigating
healthy individuals, in addition to patients with HbSS, removes
some of the confounding factors and genetic complexity that
contribute to the HbF phenotype in sickle cell disease patients.
In our efforts towards fine-mapping the HMIP-2 region, the
analysis of African-descended populations has provided suggestive
but not conclusive answers. Our data suggest that a distinct
association signal originating from African chromosomes is marked
by SNPs in the distal proportion of HMIP-2 (I-09 to I-11). While
strength of association for indirect markers is not indicative of the
specific location of the true functional variants, our eleven SNPs
should also be evaluated as potentially functional variants themselves.
In this respect it appears that I-03, which has virtually no effect in any
of the African-descended populations, is unlikely to be a causative
variant. Genetic admixture tends to confound fine-mapping through
the introduction of extended LD and additional allelic heterogeneity.
We have addressed this problem by excluding individuals with non-
African active haplotypes at the HMIP-2 locus; ultimately the
investigation of a much larger sample size of individuals with
exclusively African ancestry may be a better approach.
On the other hand, admixed populations offer specific mapping
opportunities for genetically complex diseases that vary in
prevalence across the ancestral populations[15,16]. It can also
allow the observation of known functional genetic variation in a
different population background. Alleles may differ between
similar populations, not only in frequency, but also in effect size:
the relatively small effect of I-01-tagged European haplotypes in
AG (b=0.16, compared to 0.5 in Europeans and 0.53 in the AC
group) is unexplained and might be due to a specific founder effect
connected with the history of this community. Another interesting
feature of the I-01 marker is that its allele C, which increases the
number of F cells, has a lower frequency in the AC population
when compared to the Europeans, yet the AC population has
higher F cell levels than in the European population. In
conclusion, genetic effects on F cells in admixed populations
might differ from their assumed parental populations in ways that
cannot be predicted easily.
We have also included in this report our first evaluation of HbF
levels in a sickle cell patient population. While HbF and F cells are
closely related traits, the genes that regulate each might differ,
especially in the strength of their relative effects. Encouraging in this
context is the fact that genome-wide association studies of F cell levels
in non-anaemic individuals[5] and of HbF[6] have identified the
same set of three major loci, including HMIP-2. We and others have
now shown that the F cell locusHMIP-2 also influences HbF levels in
patients with HbSS[14]. The statistical power provided by our small
and heterogeneous group of HbSS patients does not allow much
more than simple detection of the effect of the overall locus. The
drop in association seen after exclusion of non-African effects seems
to indicate that European alleles contribute to the variance of FC
levels in admixed patients, but the independent association with
African-derived polymorphism remains.
With this study we have shown that the HMIP-2 locus appears to
influence HbF-related traits in healthy individuals and in patients
with sickle cell anaemia of African origin. Our initial results suggest
that further extended studies of these populations complemented by
studies of participants from the African continent itself may be a
powerful approach for identifying loci involved in the determination
of HbF persistence and other quantitative traits.
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Table 2. British patients with sickle cell anaemia (HbSS): Test
for association of HbF levels with HMIP-2 markers.
HMIP-2 marker All Patients
Exclusion of non-African
haplotypes
(n =87) (n =81)
MAF b P= MAF b P=
I-01 (rs9376090) 0.02 0.567 0.226 n_a n_a n_a
I-02 (rs9399137) 0.07 0.642 0.019 0.05 0.629 0.049
I-03 (rs9402685) 0.31 20.010 0.937 0.29 0.030 0.834
I-04 (rs11759553) 0.38 0.190 0.109 0.36 0.204 0.096
I-05 (rs35959442{) 0.36 0.154 0.212 0.33 0.168 0.196
I-06 (rs4895440) 0.35 0.146 0.245 0.33 0.157 0.230
I-07 (rs4895441) 0.06 0.554 0.027 0.04 0.559 0.071
I-08 (rs9376092) 0.16 0.053 0.730 0.13 0.061 0.773
I-09 (rs9389269) 0.04 0.471 0.156 0.01 0.420 0.452
I-10 (rs9402686) 0.04 0.446 0.181 0.01 0.398 0.477
I-11 (rs11154792) 0.12 0.238 0.244 0.1 0.163 0.457
The regression is as in Table 1. Again, the analysis was repeated after exclusion
of individuals who carry the C allele of rs9376090 (I-01, 4 heterozygotes), and 2
individuals with unknown genotype at this SNP. No significant dominance
effect were detected in the patients.
doi:10.1371/journal.pone.0004218.t002
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